Pregnancy

Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Approval of ZYCUBO® (copper histidinate), the First and Only Approved Treatment for Menkes Disease in the United States

Rare Pediatric Disease Priority Review Voucher (PRV) granted by FDA at approval to be transferred from Sentynl Therapeutics to Cyprium...

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record levelsHOUSTON, TX, Jan. 10, 2026...

Best Berberine Patch for Transdermal Metabolic Support: NuraPatch Cited in Industry Analysis as Consumer Interest in Botanical Weight Management Options Grows

Examination of transdermal berberine delivery, GLP-1 pathway terminology in supplement marketing, and consumer evaluation criteria as searches for non-prescription metabolic...

Pomelo Care Raises $92 Million Series C, Reaches $1.7 Billion Valuation, to Expand Its Proven Model Beyond Maternity & Set a New National Standard for Women’s and Children’s Healthcare

Best Chocolate Weight Loss Supplement: Consumer Analysis Examines Cacao GLP-1 Research as January Wellness Interest Surges

Consumer analysis evaluates Earth Echo Cacao Bliss ingredient disclosures, ceremonial-grade processing claims, and published GLP-1 research frequently referenced in chocolate-based...

Tonix Pharmaceuticals Announces Program Updates on Phase 2/3-Ready Long-Acting Monoclonal Antibody (mAb) Designed for Seasonal Prevention of Lyme Disease (TNX-4800)

Exploring clinical development plan options including a controlled human infection model (CHIM) and a Phase 2/3 adaptive field study Expect...

Zevra Therapeutics Executes Distribution Agreement to Broaden Access to MIPLYFFA® for the Treatment of Niemann-Pick Disease Type C (NPC)

CELEBRATION, Fla., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company...

error: Content is protected !!